爱威品牌怎么样 申请店铺

我要投票 爱威在医疗器械行业中的票数:12 更新时间:2024-11-22
爱威是哪个国家的品牌?「爱威」是 爱威科技股份有限公司 旗下著名品牌。该品牌发源于湖南省长沙市,由创始人丁 * 文在2000年期间创立,经过多年的不懈努力和高速发展,现已成为行业的标杆品牌。
爱威怎么样

爱威科技股份有限公司成立于2000年3月16日,总部位于湖南长沙高新技术产业开发区,是一家按照现代企业制度组建而成的专业从事医疗器械、实验仪器、体外诊断试剂与耗材、电子产品、远程医疗网络、计算机软件、自动控制设备、医疗辅助设备等产品的研究、开发、生产、销售及相关技术服务的现代企业。公司基于“创新驱动发展”战略,专注于临床医疗检验设备、体外诊断试剂及医用耗材的研发和产业化,自主创新研发的“医学显微镜形态学检验自动化”等多项关键共性技术处于国际出色地位。公司已成长为国内具国际竞争力的高性能医疗检验设备提供商,并于2015年2月在新三板挂牌上市(股票名称:爱威科技,股票代码:831895)。

爱威科技在国内外设立了两家全资子公司,其中湖南爱威医疗科技有限公司位于长沙岳麓区岳麓科技产业园,占地67亩,已建成高性能医疗器械及体外诊断试剂耗材研发与生产基地超过5万平方米;美国全资子公司AVETECH INC.(爱威科技(美国)有限公司)于2015年在美国马里兰州盖塞斯堡注册成立。

公司聚集了一批多学科领域的博士、硕士、本科等技术型人才,并承担了医学显微镜检验自动化湖南省工程研究中心等省部级工程研究中心的建设。公司专注于智能医学检验关键技术和相关医疗设备研发,尤其在自动显微镜形态学检验领域,形成了以国际前沿的“机器视觉技术”和“智能显微镜形态学检验技术”为核心的重大科技成果,实现了临床尿液、血液、粪便、体液等标本中有形病理成分显微图像高速可视,智能识别分类和定量计数,终结了显微镜检查只能依靠人工完成的历史。目前公司在全国30个省级行政区设立了办事机构,产品在国内装机用户已超过4000家;在国际上,产品已出口到欧洲、美洲、亚洲等国家和地区。

公司将继续秉承“科技服务健康”的核心理念,以“创造成果,实现价值,共同发展”为经营宗旨,通过自主研发和整合国际国内出色技术,采用专业的生产工艺,专注于医疗器械、实验仪器和体外诊断试剂、耗材等的研究、开发和产业化,使公司成长为国际、国内受人尊重的高性能医疗器械研发、制造和医疗健康服务行业的标杆企业,为实现“让老百姓都能享受现代医疗健康服务”的美好愿景而努力奋斗。


Founded on March 16, 2000 and headquartered in Changsha hi tech Industrial Development Zone, Hunan Province, AVIC Technology Co., Ltd. is a company established in accordance with the modern enterprise system, specializing in the research and development of medical devices, experimental instruments, in vitro diagnostic reagents and consumables, electronic products, telemedicine network, computer software, automatic control equipment, medical auxiliary equipment and other products A modern enterprise engaged in development, production, sales and related technical services. Based on the strategy of "innovation driven development", the company focuses on the R & D and industrialization of clinical medical testing equipment, in vitro diagnostic reagents and medical consumables, and many key generic technologies such as "medical microscope Morphology Test Automation" independently innovated and developed are in an outstanding position in the world. The company has grown into a high-performance medical inspection equipment provider with international competitiveness, and was listed on the new third board in February 2015 (Stock Name: AVIC technology, stock code: 831895). AVIC technology has set up two wholly-owned subsidiaries at home and abroad, of which Hunan AVIC Medical Technology Co., Ltd. is located in Yuelu science and Technology Industrial Park, Yuelu District, Changsha, covering an area of 67 mu, and has built a research and development and production base of high-performance medical devices and in vitro diagnostic reagent consumables of more than 50000 square meters; avetech Inc., a wholly-owned subsidiary of AVIC Technology (America) Co., Ltd., was in the United States in 2015 Gaicesburg, Maryland. The company has gathered a number of multi-disciplinary technical talents such as doctors, masters and undergraduates, and has undertaken the construction of provincial and ministerial engineering research centers such as Hunan Engineering Research Center of medical microscope inspection automation. The company focuses on the research and development of key technologies of intelligent medical examination and related medical equipment, especially in the field of automatic microscopic morphology examination. It has formed major scientific and technological achievements with the international cutting-edge "machine vision technology" and "intelligent microscopic morphology examination technology" as the core, realizing the high-speed microscopic image of tangible pathological components in clinical urine, blood, feces, body fluids and other specimens Visual, intelligent recognition, classification and quantitative counting have ended the history that microscopy can only be done by human. At present, the company has set up offices in 30 provincial administrative regions, with more than 4000 domestic installed users. Internationally, the products have been exported to Europe, America, Asia and other countries and regions. The company will continue to adhere to the core concept of "science and technology serve health", with the business purpose of "creating achievements, realizing value and common development", through independent research and development and integration of international and domestic excellent technology, adopting professional production technology, focusing on the research, development and industrialization of medical devices, experimental instruments, in vitro diagnostic reagents, consumables, etc., so that the company can grow into an international and national company The high-performance medical device R & D, manufacturing and medical and health service industry benchmarking enterprises that are respected by the people strive to realize the good vision of "let people enjoy modern medical and health services".

本文链接: https://brand.waitui.com/f8296e44c.html 联系电话:400-860-0071,0731-88925460

千城特选小程序码

7×24h 快讯

三六零:前三季度基于“360智脑”能力开发的互联网ToC端产品直接收入占整体营收不超2%

36氪获悉,三六零发布股票交易异常波动公告,公司于2024年10月31日披露了《三六零安全科技股份有限公司2024年第三季度报告》,2024年1-9月归属于母公司所有者的净利润为-5.79亿元。2024年前三季度,基于“360智脑”能力开发的互联网ToC端产品所产生的直接收入在整体营业收入占比不超过2%,对公司业绩不构成重大影响。

6分钟前

小鹏MONA哨兵模式将于明年一季度上线

36氪获悉,小鹏汽车董事长何小鹏在微博发文,小鹏MONA即将于2025年第一季度推出哨兵模式。

6分钟前

爱婴室:股东拟减持不超过1%公司股份

36氪获悉,爱婴室发布公告,股东莫锐强的一致行动人茂强投资、莫锐伟拟通过集中竞价交易方式合计减持公司股份不超过138.54万股(即不超过公司总股本的1%)。

6分钟前

顺丰控股在香港上市据悉计划将价格定在区间中点

顺丰控股在香港上市据悉计划将价格定在区间中点。(财联社)

6分钟前

欧洲央行副行长:降息路径比降息幅度更重要

欧洲央行副行长Luis de Guindos表示,央行显然在降息的道路上,但每次货币政策会议的降息幅度并没有那么重要。他补充说,明年薪资增长将放缓,并且欧洲央行预计通胀将向2%的目标靠拢。“如果我们对明年的通胀预测确实成为现实,那么货币政策路径是明确的,”他周五在马德里的一次会议上说。“我们是降息50个基点还是25个基点的问题就不那么重要了。”(新浪财经)

6分钟前

本页详细列出关于诚益通的品牌信息,含品牌所属公司介绍,诚益通所处行业的品牌地位及优势。
咨询